跳至主要内容
临床试验/NCT01542879
NCT01542879招募中1 期

Development of Radiation Free Whole Body MR Imaging Technique for Staging of Children With Cancer.

Heike E Daldrup-Link1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2012年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
75
试验地点
1
主要终点
Comparison of sensitivity, specificity and accuracy of WB-DW-MR scans to 18-F FDG PET scans.

研究概览

简要总结

A research study on the diagnosis of spread of disease for children who have been diagnosed with solid tumors using a new whole body imaging technique and a new MR contrast agent (ferumoxytol). Standard tests that are used to determine the extent and possible spread of a child's disease include magnetic resonance (MR) imaging, computed tomography (CT), Positron Emission Tomography (PET) as well as bone scanning, and metaiodobenzylguanidine (MIBG) scanning. The purpose of this study is to determine if newer imaging tests referred to as whole body diffusion-weighted MR and whole body PET/MR can detect the extent and spread of the disease as accurately or even better as the standard tests (CT, MR and/or PET/CT). The advantage of the new imaging test is that it is associated with no or significantly reduced radiation exposure compared to standard CT and PET/CT imaging tests. The results of whole body MR and PET/MR will be compared with that of the conventional, standard imaging studies for tumor detecting.

详细描述

Primary Objective: To compare the sensitivity, specificity and accuracy of WB-DW-MR scans (new technique) with 18F- FDG PET or 18F- FDG PET/CT or 18F- FDG PET/MR scans.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
6 Years 至 40 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of a solid extra-cranial tumor like malignant lymphoma or malignant sarcoma and
  • Scheduled for or completed a 18F-FDG-PET or 18F-FDG-PET/CT tumor staging procedure.
  • There will be no restrictions on prior treatment.
  • Very young children who need sedation or anesthesia will be excluded from the study.
  • In this pediatric & adult study, the participant or parent/guardian is consented, and the patient when a minor is given an assent form and involved in the discussion as appropriate.

排除标准

  • MR-incompatible metal implants,
  • need of sedation or claustrophobia.
  • Hemosiderosis/hemochromatosis (patients can still be included in 2nd branch without ferumoxytol)
  • There will be restrictions regarding use of other Investigational Agents: Pt with iron-overload will not receive Ferumoxytol
  • History of allergic reactions to similar compounds will be obtained and patients with a positive history of allergic reaction to iron compounds or other severe allergic reactions.will be excluded from the study.
  • Pregnant women and fetuses.

研究组 & 干预措施

WB-DW-MR scan

Experimental

simultaneous WB-DW-MR scan and 18-F FDG PET scan

干预措施: Ferumoxytol (Drug)

WB-DW-MR scan

Experimental

simultaneous WB-DW-MR scan and 18-F FDG PET scan

干预措施: WB-DW-MR scan (Procedure)

WB-DW-MR scan

Experimental

simultaneous WB-DW-MR scan and 18-F FDG PET scan

干预措施: 18-F-FDG PET scan (Procedure)

WB-DW-MR scan

Experimental

simultaneous WB-DW-MR scan and 18-F FDG PET scan

干预措施: 18-F-FDG PET/MR scan (Procedure)

结局指标

主要结局

Comparison of sensitivity, specificity and accuracy of WB-DW-MR scans to 18-F FDG PET scans.

时间窗: The outcome will be measured after image acquisition

To determine sensitivity and specificity for lesion detection on whole-body scans, the body is divided into 10 anatomical regions, and qualified professionals evaluate each region for the presence or absence of tumor lesions. These results are then compared to the gold standard (established through biopsy and follow-up imaging), allowing for the calculation of true positives, false positives, true negatives, and false negatives for each region. Sensitivity and specificity can then be calculated using these values, providing a measure of the scan's accuracy in detecting lesions across different body areas.

次要结局

  • Comparison of sensitivity, specificity and accuracy of Ferumoxytol-enhanced whole-body 18-F FDG PET/MR-scans versus standard clinical Gadolinium-enhanced whole-body 18-F FDG PET/MR-scans.(2 years)

研究者

发起方
Heike E Daldrup-Link
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Heike E Daldrup-Link

Associate Professor of Radiology

Stanford University

研究点 (1)

Loading locations...

相似试验